Pune, India, April 05, 2022 (GLOBE NEWSWIRE) -- The global autism spectrum disorder treatment market size was USD 1.85 billion in 2021. The market is projected to grow from USD 1.93 billion in 2022 to USD 3.17 billion by 2029, exhibiting a CAGR of 7.4% during the forecast period.
This information is provided by Fortune Business Insights™, in its report, titled, “Autism Spectrum Disorder Treatment Market, 2022-2029.”
The rising occurrence of ASD across the world, pooled with growing consciousness regarding the ailment and the accessible choices for numerous treatment options of several ASD diseases are the prime aspects anticipated to drive the autism spectrum disorder treatment market growth during the forecast period.
Industry Development
July 2021: The Saskatchewan Government declared that families with children detected with Autism Spectrum Disorder (ASD) will get help from extended funding. From 27th July 2021, Autism Individualized finance was made accessible for children of age 11. Children born on or before March 31, 2021, were qualified to make an application for the final payment.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autism-spectrum-disorder-therapeutics-market-101207
Growing Occurrence of Autism Spectrum Conditions to Boost Market Growth
An augmentation in the occurrence of autism spectrum disorders (ASD) is affirmatively influencing the growth of the market across the world, which has resulted in a surging demand for clinical research for efficient autism spectrum disorder therapeutics. This can enhance patient outcomes and larger precision for the treatment of these ailments. For example, as per an assembled report on global autism rates by Global Health Data Exchange, nations such as France and Portugal have the least autism rate of 0.69% and 0.71%, respectively.
Sturdy Demand for Drugs amid COVID-19 Stoked by Increasing Implementation of Telehealth to Fuel Market Growth
The unparalleled pandemic at the primary phase led to a lockdown of a number of corporations in the healthcare industry, resulting in a slug in production procedures. Moreover, the shutting of therapy centers and autistic condition-associated services led to the halt/postponement of therapy sessions for autistic children. Nevertheless, increasing anxiety stages in autistic patients and the danger of being affected by COVID-19 as these fall under vulnerable sections resulted in the sturdy embracing of telehealth systems by the patient caretakers or family.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207
Report Coverage
We present our reports that are directed with a comprehensive review approach that primarily focuses on offering accurate information. Our professionals have applied a data navigation technique that further aids us to present reliable predictions and examine the global market dynamics perfectly. Further, our analysts have gained admittance to various international as well as regional funded records for presenting the updated information so that the entrepreneurs and shareholders capitalize only in the operative areas.
Segmentation
Based on drug therapy, the global market is segmented into antipsychotic drugs, SSRIs/antidepressants, stimulants, sleep medications, and others.
Based on disease, the global market is segmented into autistic disorder, Asperger syndrome, pervasive developmental disorder, and others. The autistic disorder segment held a dominant market share in the year 2021 owing to the high prevalence of this disease type.
Based on the patient age group, the global market can be segmented into children and adults. Based on the distribution channel, the global market can be segmented into hospital pharmacies, drugs stores & retail pharmacies, and online pharmacies. Based on the region, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Quick Buy - Autism Spectrum Disorder Therapeutics Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/101207
North America to Dominate Stoked by Rising Prevalence of Autistic Population
North America held the largest autism spectrum disorder treatment market share and stood at USD 1.08 billion in 2021. The rising occurrence of autism disorder across the U.S., pooled with the surging implementation and approval of therapies are attributable to the region’s supremacy.
Growing consciousness and screening, admittance to assist, and widened diagnostic standards have made Europe the second largest region in the market.
Asia Pacific is estimated to flourish with the highest CAGR owing to the growing demand for efficient autism spectrum disorder treatment.
Government Announcements Regarding Public Welfare to Make Positive Changes in Market
Governments of several nations are incessantly trying to present new schemes for the welfare of their population. They either raise funding for treatment purposes or provide subsidies. This benefits the common public as they are unable to pay for expensive treatments.
List of Key Players Covered in the Report
- Curemark, LLC (Rye, U.S.)
- Alembic Pharmaceuticals Limited (Vadodara, India)
- Yamo Pharmaceuticals (New York, U.S.)
- PaxMedica (Woodcliff Lake, U.S.)
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Aurobindo Pharma Ltd. (Hyderabad, India)
- Otsuka Holdings Co. Ltd. (Tokyo, Japan)
- Janssen Pharmaceuticals, Inc. (Titusville, New Jersey)
- Teva Pharmaceutical Industries Ltd. (Tel Aviv, Israel)
- H. Lundbeck A/S (Copenhagen, Denmark)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/autism-spectrum-disorder-therapeutics-market-101207
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Prevalence of Autism Spectrum Disorder– Key Countries/ Regions
- Key Industry Developments (Mergers, Acquisition and Partnerships)
- Pipeline Analysis
- Economic Cost Burden for the Treatment of Autism Spectrum Disorder
- Impact of Covid-19 on the Market
- Global Autism Spectrum Disorder Treatment Market Analysis, Insights and Forecast, 2018-2029
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Therapy
- Antipsychotic Drugs
- SSRIs/Antidepressants
- Stimulants
- Sleep Medications
- Others
- Market Analysis, Insights and Forecast – By Disease
- Autistic Disorder
- Asperger’s Syndrome
- Pervasive Development Disorder (PDD)
- Others
- Market Analysis, Insights and Forecast – By Age Group
- Children
- Adults
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- North America Autism Spectrum Disorder Treatment Market Analysis, Insights and Forecast, 2018-2029
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Therapy
- Antipsychotic Drugs
- SSRIs/Antidepressants
- Stimulants
- Sleep Medications
- Others
- Market Analysis, Insights and Forecast – By Disease
- Autistic Disorder
- Asperger’s Syndrome
- Pervasive Development Disorder (PDD)
- Others
- Market Analysis, Insights and Forecast – By Age Group
- Children
- Adults
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Country
- U.S.
- By Disease
- Canada
- By Disease
- U.S.
TOC Continued….!
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/autism-spectrum-disorder-therapeutics-market-101207
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
